Skip to content

Clinical trials

Completed Breast Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Singapore Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20044
20052
20063
20076
20082
20095
20103
20112
20124
20134
20146
20156
20163
20173
20182
20194
20213
20224
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals13
National University Hospital, Singapore9
Hoffmann-La Roche8
AstraZeneca4
GlaxoSmithKline4
Puma Biotechnology, Inc.4
Genentech, Inc.3
National University of Singapore3
Bayer2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms72
Neoplasms8
Neoplasm Metastasis6
Carcinoma, Non-Small-Cell Lung4
Hereditary Sensory and Autonomic Neuropathies3
Breast Diseases2
Colorectal Neoplasms2
Endometrial Neoplasms2
Inflammatory Breast Neoplasms2
Neoplasms by Site2

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.